InsiderTrades

Form 4 for PG Procter & Gamble

Accepted 2021-08-05 00:00:00 ET · period of report 2021-08-04 · accession 0001127602-21-023134 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2021-08-05 2021-08-04 PG FergusonMchugh MaryLynn CEO - Family Care, P, G Ventur M - OptEx $78.66 +49.9K 170.5K +41% +$3.93M
D 2021-08-05 2021-08-04 PG FergusonMchugh MaryLynn CEO - Family Care, P, G Ventur S - Sale+OE $143.32 -49.9K 120.6K -29% -$7.15M
D 2021-08-05 2021-05-17 PG FergusonMchugh MaryLynn CEO - Family Care, P, G Ventur A - Grant $0.00 +116.45 2,213 +6% $0
D 2021-08-05 2021-08-04 PG FergusonMchugh MaryLynn CEO - Family Care, P, G Ventur M - OptEx $0.00 -49.9K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-08-04 M A 49,899 $78.66 170,519.84 D — — (F1) Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock.
2 Common Common Stock 2021-08-04 S D 49,899 $143.32 120,620.84 D — — (F2) Weighted average price of the shares sold. The price range was $143.25 to $143.42. Full information regarding the number of shares sold at each separate price available upon request.
3 Derivative Restricted Stock Units 2021-05-17 A A 116.45 $0.00 2,212.94 D — · — to — 116.45 Common Stock (F4) Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. (F5) These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.
4 Derivative Stock Option (Right to Buy) 2021-08-04 M D 49,899 $0.00 0 D $78.66 · 2017-02-28 to 2024-02-28 49,899 Common Stock